Who is sponsoring NCT02539342?

NCT02539342 is sponsored by Medical College of Wisconsin.

What condition does NCT02539342 study?

NCT02539342 studies Oral Mucositis.

What drugs are being tested in NCT02539342?

Interventions: Caphosol, Biotene.

What is the status of NCT02539342?

NCT02539342 is currently TERMINATED.

Last reviewed 2020-02-18 · How we verify

Caphosol Study: A Randomized Controlled Open-Labeled Trial Investigating Topical Caphosol for Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy

NCT02539342 Phase 3 TERMINATED Results posted

The purpose of this study is to determine if the administration of Caphosol rinse, at the start of chemotherapy, will prevent the development of mucositis (greater than or equal to grade 2 in children, adolescents and young adults. This is a randomized, controlled trial.

Details

Lead sponsor	Medical College of Wisconsin
Phase	Phase 3
Status	TERMINATED
Enrolment	1
Start date	2016-10
Completion	2017-03-02

Conditions

Oral Mucositis

Interventions

Caphosol
Biotene

Primary outcomes

Measure the Development of Oral Mucositis (Grade >/= 2) in Children, Adolescents and Young Adults. — 24 months
The development of Mucositis Grade \>/= 2 in children receiving chemotherapy as evaluated using CTCAE 4.0

Countries

United States